Evidence used
- No CISA KEV confirmation is currently recorded.
- A structured source references public exploit or proof-of-concept material.
- EPSS is 0.40% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
Low technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Debian findings are scoped to the named distribution, release and source package. An absent finding does not mean a package is unaffected.
A published vendor fix does not prove that a matching update is enabled and installable on a particular asset. Confirm the local package candidate before scheduling remediation.
| Distribution release | Source package | Vendor state | Fixed version | Evidence |
|---|---|---|---|---|
| Debian sidsid · source | virtualbox | Vendor fix publishedDebian records a fixed source-package version for this release. | 4.1.18-dfsg-2 | Debian Security Tracker ↗Source updated 22 Oct 2026 |
Low technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Patch availableUnspecified vulnerability in the VirtualBox component in Oracle Virtualization 4.0, 4.1, and 4.2 allows local users to affect integrity and availability via unknown vectors related to Core. NOTE: The previous information was obtained from the January 2013 Oracle CPU. Oracle has not commented on claims from another vendor that this issue is related to an incorrect comparison in the vga_draw_text function in Devices/Graphics/DevVGA.cpp, which can cause VirtualBox to "draw more lines than necessary."
Unspecified vulnerability in the VirtualBox component in Oracle Virtualization 4.0, 4.1, and 4.2 allows local users to affect integrity and availability via unknown vectors related to Core. NOTE: The previous information was obtained from the January 2013 Oracle CPU. Oracle has not commented on claims from another vendor that this issue is related to an incorrect comparison in the vga_draw_text function in Devices/Graphics/DevVGA.cpp, which can cause VirtualBox to "draw more lines than necessary."
The current structured CVE record identifies a security weakness, but the root cause requires confirmation in the linked vendor material.
An attacker operating through the affected interface may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
Unspecified vulnerability in the VirtualBox component in Oracle Virtualization 4.0, 4.1, and 4.2 allows local users to affect integrity and availability via unknown vectors related to Core. NOTE: The previous information was obtained from the January 2013 Oracle CPU. Oracle has not commented on claims from another vendor that this issue is related to an incorrect comparison in the vga_draw_text function in Devices/Graphics/DevVGA.cpp, which can cause VirtualBox to "draw more lines than necessary."
The current structured CVE record identifies a security weakness, but the root cause requires confirmation in the linked vendor material.
An attacker operating through the affected interface may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
A structured CVE source labels at least one public reference as exploit material. BlackTree has not independently validated that it is safe, reliable or weaponised.
AV:L/AC:H/Au:S/C:N/I:P/A:POperational remediation based on structured source evidence.
Published 17 Jan 2013 · Last source change 6 Aug 2024, 14:25 UTC · CWE not yet assigned
Missing structured fields: CWE classification, affected product. Missing data is not evidence of low risk; review the primary advisory.